Internal Reference Number: FOI_8652
Date Request Received: 16/05/2025 00:00:00
Date Request Replied To: 08/08/2025 00:00:00
This response was sent via: By Email
Request Summary: Drugs for MS (Multiple Sclerosis)
Request Category: Private Individuals
| Question Number 1: How many patients has your trust treated in the past six months (for any disease) with the following drugs: Drug Name Aubagio (teriflunomide) Avonex (interferon beta-1a) Betaferon (interferon beta-1b) Brabio (glatiramer acetate) Copaxone (glatiramer acetate) Extavia (beta interferon-1b) Gilenya (fingolimod) Kesimpta (ofatumumab) Lemtrada (alemtuzumab) Mavenclad (cladribine) Mayzent (siponimod) Ocrevus (ocrelizumab) Plegridy (peginterferon beta-1a) Ponvory (ponesimod) Rebif (beta interferon-1a) Tecfidera (dimethyl fumarate) Tysabri (natalizumab) Tysabri (natalizumab) Pre-filled syringes only Vumerity (diroximel fumarate) Zeposia (ozanimod) Fingolimod generic Tyruko (Natalizumab Biosimilar) | |
| Answer To Question 1: Q1 = 0 results for all the drugs listed in the last 6 months | |
| Question Number 2: How many patients has you trust treated with Rituximab for MS (Multiple Sclerosis) in the past six months? | |
| Answer To Question 2: Q2 = 0 (pharmacy said they don鈥檛 provide drugs for MS) | |
| Question Number 3: How many patients within your trust have a diagnosis of MS (Multiple Sclerosis)? | |
| Answer To Question 3: Q3 = 708 unique patients coded at any time in the past who are still alive | |
| To return to the list of all the FOI requests please click here |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
